drugset

drugset / Trial / NCT05812417

A Study to Evaluate the Effects of Renal Function on Pharmacokinetics and Safety of DA-8010

NCT05812417 ↗

Phase 1 Completed 33 enrolled Dong-A ST Co., Ltd.

Non-randomizedParallel-groupOpen-labelScreening

Summary

This Study will evaluate the effects of renal function on pharmacokinetics and safety of DA-8010

Timeline

Start: 2023-05-02
Primary completion: 2024-06-07
Completion: 2024-06-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	VELUFENACIN	Small molecule	5 mg	—

Indications